Correlation between Serum Uric Acid and Urinary Uric Acid Levels in Vatarakta (Gout): Insights from Dhatwagni Siddhanta Perspective
- Conditions
- Health Condition 1: M206- Acquired deformities of toe(s), unspecifiedHealth Condition 2: M109- Gout, unspecified
- Registration Number
- CTRI/2024/07/070927
- Lead Sponsor
- Dr Digvijay Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria:
1. Patients of Age group 30-65 years irrespective of gender.
2. Provision of informed consent.
3. Confirmed diagnosis of Vatarakta (Gout) (for Group A).
.patients of age under 30 years and above 65 years will be excluded from the study
. Individuals with known renal or hepatic diseases.
.Pregnant or lactating women.
. Individuals who were taking NSAIDs colchicine treatment Corticoids, Anticoagulants .Diabetic Patients, Diuretics or other drugs that alter uric acid Excretion .
. Patient with hepatic insufficiency (ALT or AST above 1.5 times the upper limit of normal And serum total bilirubin more than 2 times the upper limit of normal .
. Renal insufficiency ,active peptic ulcer combined with heart disease ,Malignant tumors ,active Tuberculosis or blood disease.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Generation of Empirical Data in favor of Dhatwagni Siddhant by Assessing correlation of Serum uric acid and Urinary uric acid in Vatarakta (Gout)Timepoint: At Baseline
- Secondary Outcome Measures
Name Time Method Identifying the most critical parameters by analyzing serum uric acid & urinary uric acid in the context of Dhatwagni Siddhant in Vatarakta (Gout)Timepoint: At Baseline